Correction to: Comparison of anti-fracture effectiveness of zoledronate, ibandronate and alendronate versus denosumab in a registry-based cohort study.
Judith Everts-GraberHarald BonelDaniel LehmannBrigitta GahlHansJörg HäuselmannUeli StuderHans-Rudolf ZiswilerStephan ReichenbachThomas LehmannPublished in: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)